Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients

Peer Review reports

Original Submission
10 Jan 2018	Submitted	Original manuscript
2 Apr 2018	Reviewed	Reviewer Report - Jan De Lepeleire
29 Apr 2018	Reviewed	Reviewer Report - Leon Geffen
31 May 2018	Author responded	Author comments - Lidia Blanco-Silvente
Resubmission - Version 2
31 May 2018	Submitted	Manuscript version 2
29 Jun 2018	Author responded	Author comments - Lidia Blanco-Silvente
Resubmission - Version 3
29 Jun 2018	Submitted	Manuscript version 3
Publishing
9 Jul 2018	Editorially accepted
24 Jul 2018	Article published	10.1186/s12877-018-0857-5

Back to article page